rene1986 South East
iangriff Wales
Channy London
Davidgore Northern Ireland
Lynn-xo Northern Ireland
Amiemcc Northern Ireland
PTC Therapeutics has completed patient enrollment of a pivotal clinical trial of ataluren in patients with nonsense mutation Duchenne and Becker muscular dystrophy (nmDMD/BMD) two months ahead of ...
Tags: ataluren, nonsense mutation, PTC124, PTC Therapeutics.